Pharmacokinetics/Pharmacodynamics of Caspofungin in Plasma and Peritoneal Fluid of Liver Transplant Recipients-Reference-Cited by-同舟云学术

Pharmacokinetics/Pharmacodynamics of Caspofungin in Plasma and Peritoneal Fluid of Liver Transplant Recipients

Published:2022-01-18 Issue:1 Volume:66 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Pressiat Claire¹,Ait-Ammar Nawel²³,Daniel Matthieu⁴,Hulin Anne¹⁵,Botterel Françoise²³,Levesque Eric²⁴^ORCID

Affiliation:

1. Pharmacology Unit, AP-HP, Henri Mondor Hospital, Créteil, France

2. Université Paris-Est Creteil, EnvA, DYNAMiC, Faculté de Santé de Créteil, Creteil, France

3. Parasitology and Mycology Unit, Department of Prevention, Diagnosis, and Treatment of Infections, AP-HP, Henri Mondor Hospital, Créteil, France

4. Department of Anaesthesia and Surgical Intensive Care, Liver Intensive Care Unit, AP-HP, Henri Mondor Hospital, Créteil, France

5. EA 7375, EC2M3, Oncomix, Université Paris-Est Créteil, Faculté de Santé de Créteil, Institut Pasteur, Paris, France

Abstract

The weaker diffusion of echinocandins in the peritoneal fluid (PF) could promote Candida -resistant isolates. The aim of this study was to analyze the pharmacokinetics (PK)/pharmacodynamics (PD) of caspofungin in plasma and PF samples from liver transplant recipients.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.01187-21

Reference43 articles.

1. Infections in liver transplant recipients

2. Guidelines for management of intra-abdominal infections

3. Intra-abdominal candidiasis: the guidelines—forgotten non-candidemic invasive candidiasis

4. Invasive fungal infection before and after liver transplantation

5. Invasive pulmonary aspergillosis in cirrhotic patients: analysis of a 10-year clinical experience

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Quality Control of a Population Pharmacokinetic Model Library for Caspofungin;Pharmaceutics;2024-06-17

2. Modeling of intravenous caspofungin administration using an intestine-on-chip reveals altered Candida albicans microcolonies and pathogenicity;Biomaterials;2024-06

3. Antidermatophyte activity and PK/PD of ME1111 in a guinea pig model of tinea corporis;The Journal of Antibiotics;2024-05-20

4. Pharmacokinetic and pharmacodynamic considerations of antibiotics and antifungals in liver transplantation recipients;Liver Transplantation;2022-06-27